Primacyt

Primacyt is a biotechnology company headquartered in Schwerin, Germany, specializing in the provision of high-quality human and animal hepatocytes for pharmaceutical research and drug development. The company offers a specialized portfolio of in vitro services and products, including cryopreserved liver cells, HepDirect culture systems, and HEPI-SCREEN assays used for metabolism and toxicology testing. Primacyt is recognized for its expertise in cytochrome P450 induction studies and ADME-Tox screening, providing essential data for regulatory drug safety assessments. In January 2022, Primacyt was acquired by LifeNet Health, integrating its specialized liver cell technologies into the LifeNet Health LifeSciences division. This synergy enhances the availability of human cell-based research tools and supports the pharmaceutical industry's move toward alternative testing methods to animal models.